Confo Therapeutics

1 follower


Confo Therapeutics is an emerging drug discovery company built around a disruptive technology to enable the discovery of GPCR agonists. The CONFO® technology uses single domain antibodies to lock inherently unstable GPCRs in the druggable conformation and uses this stabilized complex as a superior s... Read more

Industries

Headquarters

Elsene, Belgium

Employees

11-50

Links


Org chart

Collapse
Frank Landolt
Chief Counsel, Intellectual Property & Legal
Paolo Vicini
Chief Development Officer
Marc Moens
Head, Finance & HR
Stephen Dowd
Chief Business Officer

Board & advisors

Edward van Wezel
Board Director
Jan Steyaert
Founder & Chairman, Scientific Advisory Board
Rob Scott
Independent Director
Radu Aricescu
Scientific Advisory Board Member
Peter Kolb
Scientific Advisory Board Member
Graeme Milligan
Scientific Advisory Board Member
Karl Nägler
Director
Tim Corn
Medical Advisor